Eton Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ETON, and when can generic versions of ETON drugs launch?
ETON has four approved drugs.
There are three US patents protecting ETON drugs.
There are forty-four patent family members on ETON drugs in twenty-four countries and eight supplementary protection certificates in five countries.
Summary for Eton
| International Patents: | 44 |
| US Patents: | 3 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
| Patent Litigation for Eton: | See patent lawsuits for Eton |
| PTAB Cases with Eton as petitioner: | See PTAB cases with Eton as petitioner |
Drugs and US Patents for Eton
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-001 | Sep 29, 2020 | RX | Yes | No | 9,675,559 | See Plans and Pricing | See Plans and Pricing | ||||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-004 | Sep 29, 2020 | RX | Yes | Yes | 9,675,559 | See Plans and Pricing | See Plans and Pricing | ||||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-002 | Sep 29, 2020 | RX | Yes | No | 9,649,280 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Eton | ALKINDI SPRINKLE | hydrocortisone | GRANULE;ORAL | 213876-003 | Sep 29, 2020 | RX | Yes | No | 9,649,280 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eton Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Slovenia | 2978414 | See Plans and Pricing |
| South Korea | 20160011205 | See Plans and Pricing |
| Spain | 2813382 | See Plans and Pricing |
| Canada | 2909060 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eton Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1110543 | SPC/GB08/005 | United Kingdom | See Plans and Pricing | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022. |
| 0809498 | SPC/GB10/012 | United Kingdom | See Plans and Pricing | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 1534313 | 2015/071 | Ireland | See Plans and Pricing | PRODUCT NAME: AN OCULAR IRRIGATION SOLUTION COMPRISING PHENYLEPHRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND KETOROLAC OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/15/1018 20150728 |
| 1110543 | 08C0004 | France | See Plans and Pricing | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
